Rigel Reports First Quarter 2026 Financial Results - PR Newswire

Rigel Reports First Quarter 2026 Financial Results  PR Newswire

2026 May 8 – Comet R3 PanSTARRS Before Rigel - NASA (.gov)

2026 May 8 – Comet R3 PanSTARRS Before Rigel  NASA (.gov)

Lilly exits Rigel alliance, adding to RIPK1 scrap heap - BioSpace

Lilly exits Rigel alliance, adding to RIPK1 scrap heap  BioSpace

Lilly reneges on remainder of Rigel deal in another blow for RIPK1 inhibitors - Fierce Biotech

Lilly reneges on remainder of Rigel deal in another blow for RIPK1 inhibitors  Fierce Biotech

Rear Admiral Rigel D. Pirrone - navy.mil

Rear Admiral Rigel D. Pirrone  navy.mil

Is the Options Market Predicting a Spike in Rigel Pharmaceuticals Stock? - Yahoo Finance

Is the Options Market Predicting a Spike in Rigel Pharmaceuticals Stock?  Yahoo Finance

Blue-white Rigel is Orion’s brightest star - EarthSky

Blue-white Rigel is Orion’s brightest star  EarthSky

Darrell Rigel, MD, MS’s Melanoma Updates from AAD 2026 - Dermatology Times

Darrell Rigel, MD, MS’s Melanoma Updates from AAD 2026  Dermatology Times

Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update -...

Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update  PR Newswire

Rigel Pharmaceuticals Q4 Earnings Call Highlights - Yahoo Finance

Rigel Pharmaceuticals Q4 Earnings Call Highlights  Yahoo Finance

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - PR...

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)  PR Newswire

Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates - Yahoo Finance

Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates  Yahoo Finance

Rigel Appoints Michael P. Miller to the Board of Directors - PR Newswire

Rigel Appoints Michael P. Miller to the Board of Directors  PR Newswire

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial...

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update  Yahoo Finance

Rigel Provides Business Update and 2026 Outlook - PR Newswire

Rigel Provides Business Update and 2026 Outlook  PR Newswire

How The Rigel Pharmaceuticals (RIGL) Story Is Shifting With New Targets And Pipeline Progress - Y...

How The Rigel Pharmaceuticals (RIGL) Story Is Shifting With New Targets And Pipeline Progress  Yahoo Finance

Rigel Announces Publication of Final ARROW Clinical Trial Data on GAVRETO® (pralsetinib) in Patie...

Rigel Announces Publication of Final ARROW Clinical Trial Data on GAVRETO® (pralsetinib) in Patients with RET+ NSCLC in the Journal of Clinical Oncology  PR Newswire

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - PR...

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)  PR Newswire

Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update - PR Newswire

Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update  PR Newswire

Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lowe...

Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition  PR Newswire

Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy? - Yahoo Finance

Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy?  Yahoo Finance

Pauline E. (Rader) Rigel Obituary January 10, 2017 - Love-Heitmeyer Funeral Home

Pauline E. (Rader) Rigel Obituary January 10, 2017  Love-Heitmeyer Funeral Home

Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 ...

Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS  PR Newswire

Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/...

Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology  PR Newswire

Rigel Pharmaceuticals, Inc. (RIGL) Releases Preliminary Results for Q4 2025 - Yahoo Finance

Rigel Pharmaceuticals, Inc. (RIGL) Releases Preliminary Results for Q4 2025  Yahoo Finance

Is Rigel Pharmaceuticals (RIGL) 2026 Revenue Guidance Reframing Its Commercial-Led Investment Nar...

Is Rigel Pharmaceuticals (RIGL) 2026 Revenue Guidance Reframing Its Commercial-Led Investment Narrative?  Yahoo Finance

A Look At Rigel Pharmaceuticals (RIGL) Valuation After Issuing 2026 Revenue Guidance - Yahoo Finance

A Look At Rigel Pharmaceuticals (RIGL) Valuation After Issuing 2026 Revenue Guidance  Yahoo Finance

Why Analysts Say The Rigel Pharmaceuticals (RIGL) Story Is Shifting After Q3 And 2025 Guidance - ...

Why Analysts Say The Rigel Pharmaceuticals (RIGL) Story Is Shifting After Q3 And 2025 Guidance  Yahoo Finance

How The Narrative Around Rigel Pharmaceuticals (RIGL) Is Shifting With Raised Guidance And Cash F...

How The Narrative Around Rigel Pharmaceuticals (RIGL) Is Shifting With Raised Guidance And Cash Flow  Yahoo Finance

Laura R. (Cupp) Rigel Obituary May 5, 2024 - Love-Heitmeyer Funeral Home

Laura R. (Cupp) Rigel Obituary May 5, 2024  Love-Heitmeyer Funeral Home

Rigel Pharmaceuticals: Growing Where It Matters (NASDAQ:RIGL) - Seeking Alpha

Rigel Pharmaceuticals: Growing Where It Matters (NASDAQ:RIGL)  Seeking Alpha

Rigel Pharmaceuticals Was Easy To Dismiss - Now It's Hard To Ignore (Rating Upgrade) - Seeking Alpha

Rigel Pharmaceuticals Was Easy To Dismiss - Now It's Hard To Ignore (Rating Upgrade)  Seeking Alpha

Rigel Pharmaceuticals (RIGL) Tops Q3 Earnings and Revenue Estimates - Yahoo Finance

Rigel Pharmaceuticals (RIGL) Tops Q3 Earnings and Revenue Estimates  Yahoo Finance

Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update - PR Newswire

Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update  PR Newswire

Rigel to Present at the Jefferies Global Healthcare Conference in London - PR Newswire

Rigel to Present at the Jefferies Global Healthcare Conference in London  PR Newswire

Lilly pulls out of CNS portion of $960M RIPK1 inhibitor collab with Rigel - Fierce Biotech

Lilly pulls out of CNS portion of $960M RIPK1 inhibitor collab with Rigel  Fierce Biotech

How the Story Behind Rigel Pharmaceuticals Is Evolving After Analyst Upgrades and New Guidance - ...

How the Story Behind Rigel Pharmaceuticals Is Evolving After Analyst Upgrades and New Guidance  Yahoo Finance

Onco360® Has Partnered with Rigel Pharmaceuticals to Add Three Therapies to Its Limited Distribut...

Onco360® Has Partnered with Rigel Pharmaceuticals to Add Three Therapies to Its Limited Distribution Portfolio  Yahoo Finance

Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals...

Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics  Yahoo Finance

Rigel Pharmaceuticals (RIGL) Profitability Rebound Reinforces Bullish Valuation Narratives - Yaho...

Rigel Pharmaceuticals (RIGL) Profitability Rebound Reinforces Bullish Valuation Narratives  Yahoo Finance

Rigel Pharmaceuticals (RIGL) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

Rigel Pharmaceuticals (RIGL) is a Great Momentum Stock: Should You Buy?  Yahoo Finance

Rigel Pharma stock slides on 2026 outlook (RIGL:NASDAQ) - Seeking Alpha

Rigel Pharma stock slides on 2026 outlook (RIGL:NASDAQ)  Seeking Alpha

Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology...

Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition  PR Newswire

Rigel Pharmaceuticals (RIGL) Is Up 21.7% After Strong Q3 Results and Raised 2025 Guidance - Yahoo...

Rigel Pharmaceuticals (RIGL) Is Up 21.7% After Strong Q3 Results and Raised 2025 Guidance  Yahoo Finance

Rigel Pharmaceuticals Inc (RIGL) Q3 2025 Earnings Call Highlights: Record Revenue and Raised ... ...

Rigel Pharmaceuticals Inc (RIGL) Q3 2025 Earnings Call Highlights: Record Revenue and Raised ...  Yahoo Finance

Rigel Pharmaceuticals: Continued Financial Performance, Catalysts In 2026 (RIGL) - Seeking Alpha

Rigel Pharmaceuticals: Continued Financial Performance, Catalysts In 2026 (RIGL)  Seeking Alpha

Rigel Pharmaceuticals: Behind The Huge Rally (NASDAQ:RIGL) - Seeking Alpha

Rigel Pharmaceuticals: Behind The Huge Rally (NASDAQ:RIGL)  Seeking Alpha

Douglas Jon Rigel - Richland Source

Douglas Jon Rigel  Richland Source

Rigel Pharmaceuticals CEO Raul Rodriguez on profitability and product growth - CNBC

Rigel Pharmaceuticals CEO Raul Rodriguez on profitability and product growth  CNBC

Rigel Pharma: Formulating A Game Plan For 2026 - Seeking Alpha

Rigel Pharma: Formulating A Game Plan For 2026  Seeking Alpha

Assessing Rigel Pharmaceuticals (RIGL) Valuation After Strong Q4 And Full Year 2025 Earnings Resu...

Assessing Rigel Pharmaceuticals (RIGL) Valuation After Strong Q4 And Full Year 2025 Earnings Results  simplywall.st

'Marshals' Star Luke Grimes Says Son Rigel Enjoying His Music Is “The Most Flattering Thing Of Al...

'Marshals' Star Luke Grimes Says Son Rigel Enjoying His Music Is “The Most Flattering Thing Of All Time”  Music Mayhem

Instagrammable eCooler Is Built Like a Tank: TRAVOCA Rigel 25 Dual Zone Review - GearJunkie

Instagrammable eCooler Is Built Like a Tank: TRAVOCA Rigel 25 Dual Zone Review  GearJunkie

Timothy Rigel Obituary (1949 - 2026) - Springfield, OH - Dayton Daily News - Legacy obituary

Timothy Rigel Obituary (1949 - 2026) - Springfield, OH - Dayton Daily News  Legacy obituary

Rigel Pharmaceuticals (RIGL) Projects Revenue Decline for 2026 - GuruFocus

Rigel Pharmaceuticals (RIGL) Projects Revenue Decline for 2026  GuruFocus

Six new Rigel employees get stock awards that vest over 4 years - Stock Titan

Six new Rigel employees get stock awards that vest over 4 years  Stock Titan

Rigel Pharma: Q3 Earnings Showcase Robust Growth (NASDAQ:RIGL) - Seeking Alpha

Rigel Pharma: Q3 Earnings Showcase Robust Growth (NASDAQ:RIGL)  Seeking Alpha

Rigel Pharmaceuticals (RIGL) Is Down 7.7% After Issuing Detailed 2026 Revenue Mix Guidance – Has ...

Rigel Pharmaceuticals (RIGL) Is Down 7.7% After Issuing Detailed 2026 Revenue Mix Guidance – Has The Bull Case Changed?  simplywall.st

Is Rigel Pharmaceuticals (NASDAQ:RIGL) Using Too Much Debt? - simplywall.st

Is Rigel Pharmaceuticals (NASDAQ:RIGL) Using Too Much Debt?  simplywall.st

Veteran biotech commercial leader Michael P. Miller joins Rigel board - Stock Titan

Veteran biotech commercial leader Michael P. Miller joins Rigel board  Stock Titan

Insiders Who Sold Rigel Pharmaceuticals Made The Right Call As Market Cap Slides By US$97m - simp...

Insiders Who Sold Rigel Pharmaceuticals Made The Right Call As Market Cap Slides By US$97m  simplywall.st

Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Price Is Right But Growth Is Lacking After Shares Roc...

Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Price Is Right But Growth Is Lacking After Shares Rocket 35%  simplywall.st

TRAVOCA Launches Kickstarter for Rigel Dual-Zone eCooler - Outdoor Sportswire

TRAVOCA Launches Kickstarter for Rigel Dual-Zone eCooler  Outdoor Sportswire

Rigel Announces Strong Preliminary 2025 Results and Outlook - TipRanks

Rigel Announces Strong Preliminary 2025 Results and Outlook  TipRanks

Can Tavalisse Drive Rigel's Growth Through the Rest of 2025? - Yahoo Finance

Can Tavalisse Drive Rigel's Growth Through the Rest of 2025?  Yahoo Finance

Is Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Trading At A 23% Discount? - simplywall.st

Is Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Trading At A 23% Discount?  simplywall.st

Rigel Provides Business Update and 2026 Outlook – Company Announcement - Financial Times

Rigel Provides Business Update and 2026 Outlook – Company Announcement  Financial Times

Wartales - Official 'The Curse of Rigel ' Expansion Launch Trailer - IGN Africa

Wartales - Official 'The Curse of Rigel ' Expansion Launch Trailer  IGN Africa

Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress - PR Ne...

Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress  PR Newswire

Rigel Tepshi - Transfermarkt

Rigel Tepshi  Transfermarkt

Wartales: The Curse of Rigel DLC Arrives Next Week - Bleeding Cool News

Wartales: The Curse of Rigel DLC Arrives Next Week  Bleeding Cool News

Alfonzo Rigel Obituary in Durham at American Cremation and Funeral Service - articobits.com

Alfonzo Rigel Obituary in Durham at American Cremation and Funeral Service  articobits.com

Alfonzo Rigel Obituary (2025) - Durham, NC - American Cremation & Funeral Service - Legacy obituary

Alfonzo Rigel Obituary (2025) - Durham, NC - American Cremation & Funeral Service  Legacy obituary

Rigel Announces Availability of REZLIDHIA™ (olutasidenib) in the U.S. for the Treatment of Adult ...

Rigel Announces Availability of REZLIDHIA™ (olutasidenib) in the U.S. for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with a Susceptible IDH1 Mutation  PR Newswire

Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO® - PR Newswire

Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO®  PR Newswire

Rigel Appoints Mark W. Frohlich, M.D. to Board of Directors - PR Newswire

Rigel Appoints Mark W. Frohlich, M.D. to Board of Directors  PR Newswire

Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - ...

Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update  PR Newswire

Berkeley Councilmember Rigel Robinson to step down, end run for mayor, citing 'harassment, stalki...

Berkeley Councilmember Rigel Robinson to step down, end run for mayor, citing 'harassment, stalking and threats'  Berkeleyside

Rigel Reports First Quarter 2025 Financial Results and Provides Business Update - PR Newswire

Rigel Reports First Quarter 2025 Financial Results and Provides Business Update  PR Newswire

Rigel Announces Reverse Stock Split - PR Newswire

Rigel Announces Reverse Stock Split  PR Newswire

Rigel Announces Settlement Agreement Resolving TAVALISSE® (fostamatinib disodium hexahydrate) Pat...

Rigel Announces Settlement Agreement Resolving TAVALISSE® (fostamatinib disodium hexahydrate) Patent Litigation  PR Newswire

Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republi...

Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republic of Korea and Taiwan  PR Newswire

MD Anderson and Rigel collaborate to advance olutasidenib in AML | UT MD Anderson - UT MD Anderson

MD Anderson and Rigel collaborate to advance olutasidenib in AML | UT MD Anderson  UT MD Anderson

Rigel Announces Publication of REZLIDHIA™ (olutasidenib) Phase 2 Clinical Results in Blood Advanc...

Rigel Announces Publication of REZLIDHIA™ (olutasidenib) Phase 2 Clinical Results in Blood Advances  PR Newswire

Obituary for Vonda Mae Rigel - shirleyandstout.com

Obituary for Vonda Mae Rigel  shirleyandstout.com

2024 October 31 - Rigel and the Witch Head Nebula - NASA (.gov)

2024 October 31 - Rigel and the Witch Head Nebula  NASA (.gov)

Lilly and Rigel Enter Strategic Collaboration to Develop RIPK1 Inhibitors for the Potential Treat...

Lilly and Rigel Enter Strategic Collaboration to Develop RIPK1 Inhibitors for the Potential Treatment of Immunological and Neurodegenerative Diseases  investor.lilly.com

Rigel Secures Credit Facility for Up to $60 Million - PR Newswire

Rigel Secures Credit Facility for Up to $60 Million  PR Newswire

Behind the badge: Artist/Sheriff Danny Rigel - WDAM-TV

Behind the badge: Artist/Sheriff Danny Rigel  WDAM-TV

Rigel Awarded $16.5 Million from U.S. Department of Defense for Phase 3 Clinical Trial of Fostama...

Rigel Awarded $16.5 Million from U.S. Department of Defense for Phase 3 Clinical Trial of Fostamatinib in COVID-19 Patients  PR Newswire

Rigel Awarded $16.5 Million from DoD for Phase 3 Trial of Fostamatinib in COVID-19 Patients - Glo...

Rigel Awarded $16.5 Million from DoD for Phase 3 Trial of Fostamatinib in COVID-19 Patients  Global Biodefense

After Roche breakup, Blueprint Medicines finds Gavreto a new home at Rigel - Fierce Pharma

After Roche breakup, Blueprint Medicines finds Gavreto a new home at Rigel  Fierce Pharma

Rigel wins US approval of rival drug to Servier leukemia treatment - BioPharma Dive

Rigel wins US approval of rival drug to Servier leukemia treatment  BioPharma Dive

Obituary for Cynthia S. Rigel - Hanneman Family Funeral Homes & Crematory

Obituary for Cynthia S. Rigel  Hanneman Family Funeral Homes & Crematory

Rigel Cabinetry launches digital catalog - LBM Journal

Rigel Cabinetry launches digital catalog  LBM Journal

2023 April 7 - Rigel Wide - NASA (.gov)

2023 April 7 - Rigel Wide  NASA (.gov)

Rigel bets $230M that Forma's leukemia drug gets in formation with FDA - Fierce Biotech

Rigel bets $230M that Forma's leukemia drug gets in formation with FDA  Fierce Biotech

2022 January 24 - Rigel and the Witch Head Nebula - NASA (.gov)

2022 January 24 - Rigel and the Witch Head Nebula  NASA (.gov)

Rigel Pharmaceuticals Enters Collaboration and License Agreement with Grifols, S.A. to Commercial...

Rigel Pharmaceuticals Enters Collaboration and License Agreement with Grifols, S.A. to Commercialize Fostamatinib in Europe  PR Newswire

Eyes of the Rigel - Literary Hub

Eyes of the Rigel  Literary Hub